TRC120038, a Novel Dual AT<sub><b>1</b></sub>/ET<sub><b>A</b></sub> Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats

<table>Representative pressure-volume loops from left ventricle of male ob-ZSF1 rats treated with vehicle, TRC120038, or candesartan.</table>

International Journal of Hypertension

fig3

Figure 3

Figure 3: TRC120038, a Novel Dual AT<sub><b>1</b></sub>/ET<sub><b>A</b></sub> Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats 

International Journal of Hypertension

TRC120038, a Novel Dual AT1/ETA Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats

Figure 3

TRC120038, a Novel Dual AT₁/ET_A Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats